About Evonetix
Evonetix is a company based in Saffron Walden (United Kingdom) founded in 2015 by Raymond Anthony Edgson and Matthew Hayes.. Evonetix has raised $70.01 million across 7 funding rounds from investors including Gov.uk, Cambridge Consultants and Molten Ventures. The company has 49 employees as of September 30, 2020. Evonetix offers products and services including Gene Synthesis Platform and Gene Foundry Technology. Evonetix operates in a competitive market with competitors including Amyris, GSK, Inscripta, Avidity Biosciences and Pivot Bio, among others.
- Headquarter Saffron Walden, United Kingdom
- Employees 49 as on 30 Sep, 2020
- Founders Raymond Anthony Edgson, Matthew Hayes
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Evonetix Ltd
- Date of Incorporation 16 Feb, 2015
- Jurisdiction CAMBRIDGE, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$70.01 M (USD)
in 7 rounds
-
Latest Funding Round
$24 M (USD), Series B
Feb 07, 2023
-
Investors
Gov.uk
& 10 more
-
Employee Count
49
as on Sep 30, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Evonetix
Evonetix offers a comprehensive portfolio of products and services, including Gene Synthesis Platform and Gene Foundry Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for synthesizing high-quality DNA for research applications
Tools enabling scalable DNA production for labs and partners
Unlock access to complete
Unlock access to complete
Funding Insights of Evonetix
Evonetix has successfully raised a total of $70.01M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $24 million completed in February 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series B — $24.0M
-
First Round
First Round
(04 Aug 2015)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2023 | Amount | Series B - Evonetix | Valuation | Foresite Capital | |
| Mar, 2020 | Amount | Series B - Evonetix | Valuation | Foresite Capital | |
| Jul, 2018 | Amount | Grant - Evonetix | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Evonetix
Evonetix has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Gov.uk, Cambridge Consultants and Molten Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Multi-stage investment firm invests in healthcare and life sciences companies
|
Founded Year | Domain | Location | |
|
Venture capital fund focused on deep tech, consumer tech, health tech, SaaS, and multiple sectors
|
Founded Year | Domain | Location | |
|
Multiple sectors are invested in by Morningside, a VC fund.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Evonetix
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Evonetix
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Evonetix Comparisons
Competitors of Evonetix
Evonetix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amyris, GSK, Inscripta, Avidity Biosciences and Pivot Bio, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of renewable products for industrial solutions
|
|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Speech recognition solutions are provided by Inscripta for healthcare professionals.
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Nitrogen-fixing microbes for corn crop nutrition are developed and applied.
|
|
| domain | founded_year | HQ Location |
Gene editing-based cultured ingredients are provided for agriculture.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Evonetix
Frequently Asked Questions about Evonetix
When was Evonetix founded?
Evonetix was founded in 2015.
Where is Evonetix located?
Evonetix is headquartered in Saffron Walden, United Kingdom. It is registered at Saffron Walden, Essex, United Kingdom.
Who is the current CEO of Evonetix?
Timothy Brears is the current CEO of Evonetix.
Is Evonetix a funded company?
Evonetix is a funded company, having raised a total of $70.01M across 7 funding rounds to date. The company's 1st funding round was a Grant of $1.72M, raised on Aug 04, 2015.
How many employees does Evonetix have?
As of Sep 30, 2020, the latest employee count at Evonetix is 49.
What does Evonetix do?
Evonetix was founded in 2015 and is based in Saffron Walden, United Kingdom. A technology platform for synthetic biology is offered, focusing on DNA synthesis for genes with high GC content. Silicon arrays, produced through semiconductor microfabrication, are employed to create miniaturized reaction sites. Operations center on biotech advancements, supporting gene assembly in controlled environments.
Who are the top competitors of Evonetix?
Evonetix's top competitors include Syngenta, Sutro Biopharma and Avidity Biosciences.
What products or services does Evonetix offer?
Evonetix offers Gene Synthesis Platform and Gene Foundry Technology.
Who are Evonetix's investors?
Evonetix has 11 investors. Key investors include Gov.uk, Cambridge Consultants, Molten Ventures, Draper Esprit, and Foresite Capital.
What is Evonetix's valuation?
The valuation of Evonetix is $609.5M as of Jan 2018.